| Kenneth P Moses, MD | |
|
2107 Livingston St, Suite A, Oakland, CA 94606-5218 | |
| (510) 436-9000 | |
| (510) 436-9013 |
| Full Name | Kenneth P Moses |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 26 Years |
| Location | 2107 Livingston St, Oakland, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275543845 | NPI | - | NPPES |
| 00A709050 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A70905 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Glenn Medical Center | Willows, CA | Hospital |
| Enloe Medical Center | Chico, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Specialty Physicians Group Inc | 6103198460 | 16 |
News Archive
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory, National Human Genome Research Institute and institutions across the U.S. declare in a Leading Edge commentary in Cell.
Exelixis, Inc. today reported updated interim data from three ongoing trials of XL765 (SAR245409), an orally available small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mTOR. Activation of the PI3K pathway is a frequent event in human tumors, promoting cell proliferation, survival, and resistance to chemotherapy and radiotherapy.
New research led by Queen's University Belfast has discovered how a genomic approach to understanding bowel (colorectal) cancer could improve the prognosis and quality of life for patients.
The Methodist Neurological Institute's Eddy Scurlock Stroke Center, the largest stroke unit in Houston's Texas Medical Center, is the first hospital in the United States to receive a comprehensive stroke center certification by DNV Healthcare Inc.
Current research provides a novel model for rheumatoid arthritis research. The related report by LaBranche et al, "Characterization of the KRN cell transfer model of rheumatoid arthritis, a chronic yet synchronized version of the K/BxN mouse," appears in the September 2010 issue of The American Journal of Pathology.
› Verified 9 days ago
| Entity Name | Doctors Managed Emergency Medical Group Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922241843 PECOS PAC ID: 8123931367 Enrollment ID: O20031112000527 |
News Archive
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory, National Human Genome Research Institute and institutions across the U.S. declare in a Leading Edge commentary in Cell.
Exelixis, Inc. today reported updated interim data from three ongoing trials of XL765 (SAR245409), an orally available small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mTOR. Activation of the PI3K pathway is a frequent event in human tumors, promoting cell proliferation, survival, and resistance to chemotherapy and radiotherapy.
New research led by Queen's University Belfast has discovered how a genomic approach to understanding bowel (colorectal) cancer could improve the prognosis and quality of life for patients.
The Methodist Neurological Institute's Eddy Scurlock Stroke Center, the largest stroke unit in Houston's Texas Medical Center, is the first hospital in the United States to receive a comprehensive stroke center certification by DNV Healthcare Inc.
Current research provides a novel model for rheumatoid arthritis research. The related report by LaBranche et al, "Characterization of the KRN cell transfer model of rheumatoid arthritis, a chronic yet synchronized version of the K/BxN mouse," appears in the September 2010 issue of The American Journal of Pathology.
› Verified 9 days ago
| Entity Name | Chase Dennis Emergency Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033152350 PECOS PAC ID: 2264345172 Enrollment ID: O20040729000498 |
News Archive
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory, National Human Genome Research Institute and institutions across the U.S. declare in a Leading Edge commentary in Cell.
Exelixis, Inc. today reported updated interim data from three ongoing trials of XL765 (SAR245409), an orally available small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mTOR. Activation of the PI3K pathway is a frequent event in human tumors, promoting cell proliferation, survival, and resistance to chemotherapy and radiotherapy.
New research led by Queen's University Belfast has discovered how a genomic approach to understanding bowel (colorectal) cancer could improve the prognosis and quality of life for patients.
The Methodist Neurological Institute's Eddy Scurlock Stroke Center, the largest stroke unit in Houston's Texas Medical Center, is the first hospital in the United States to receive a comprehensive stroke center certification by DNV Healthcare Inc.
Current research provides a novel model for rheumatoid arthritis research. The related report by LaBranche et al, "Characterization of the KRN cell transfer model of rheumatoid arthritis, a chronic yet synchronized version of the K/BxN mouse," appears in the September 2010 issue of The American Journal of Pathology.
› Verified 9 days ago
| Entity Name | Premier Emergency Physicians Of California Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578747606 PECOS PAC ID: 3870405384 Enrollment ID: O20041101000810 |
News Archive
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory, National Human Genome Research Institute and institutions across the U.S. declare in a Leading Edge commentary in Cell.
Exelixis, Inc. today reported updated interim data from three ongoing trials of XL765 (SAR245409), an orally available small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mTOR. Activation of the PI3K pathway is a frequent event in human tumors, promoting cell proliferation, survival, and resistance to chemotherapy and radiotherapy.
New research led by Queen's University Belfast has discovered how a genomic approach to understanding bowel (colorectal) cancer could improve the prognosis and quality of life for patients.
The Methodist Neurological Institute's Eddy Scurlock Stroke Center, the largest stroke unit in Houston's Texas Medical Center, is the first hospital in the United States to receive a comprehensive stroke center certification by DNV Healthcare Inc.
Current research provides a novel model for rheumatoid arthritis research. The related report by LaBranche et al, "Characterization of the KRN cell transfer model of rheumatoid arthritis, a chronic yet synchronized version of the K/BxN mouse," appears in the September 2010 issue of The American Journal of Pathology.
› Verified 9 days ago
| Entity Name | Eastern Plumas Health Care District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245236850 PECOS PAC ID: 4587576889 Enrollment ID: O20050329001076 |
News Archive
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory, National Human Genome Research Institute and institutions across the U.S. declare in a Leading Edge commentary in Cell.
Exelixis, Inc. today reported updated interim data from three ongoing trials of XL765 (SAR245409), an orally available small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mTOR. Activation of the PI3K pathway is a frequent event in human tumors, promoting cell proliferation, survival, and resistance to chemotherapy and radiotherapy.
New research led by Queen's University Belfast has discovered how a genomic approach to understanding bowel (colorectal) cancer could improve the prognosis and quality of life for patients.
The Methodist Neurological Institute's Eddy Scurlock Stroke Center, the largest stroke unit in Houston's Texas Medical Center, is the first hospital in the United States to receive a comprehensive stroke center certification by DNV Healthcare Inc.
Current research provides a novel model for rheumatoid arthritis research. The related report by LaBranche et al, "Characterization of the KRN cell transfer model of rheumatoid arthritis, a chronic yet synchronized version of the K/BxN mouse," appears in the September 2010 issue of The American Journal of Pathology.
› Verified 9 days ago
| Entity Name | Glenn Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1336187178 PECOS PAC ID: 3870505035 Enrollment ID: O20070705000269 |
News Archive
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory, National Human Genome Research Institute and institutions across the U.S. declare in a Leading Edge commentary in Cell.
Exelixis, Inc. today reported updated interim data from three ongoing trials of XL765 (SAR245409), an orally available small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mTOR. Activation of the PI3K pathway is a frequent event in human tumors, promoting cell proliferation, survival, and resistance to chemotherapy and radiotherapy.
New research led by Queen's University Belfast has discovered how a genomic approach to understanding bowel (colorectal) cancer could improve the prognosis and quality of life for patients.
The Methodist Neurological Institute's Eddy Scurlock Stroke Center, the largest stroke unit in Houston's Texas Medical Center, is the first hospital in the United States to receive a comprehensive stroke center certification by DNV Healthcare Inc.
Current research provides a novel model for rheumatoid arthritis research. The related report by LaBranche et al, "Characterization of the KRN cell transfer model of rheumatoid arthritis, a chronic yet synchronized version of the K/BxN mouse," appears in the September 2010 issue of The American Journal of Pathology.
› Verified 9 days ago
| Entity Name | American Specialty Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568992923 PECOS PAC ID: 6103198460 Enrollment ID: O20170821003230 |
News Archive
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory, National Human Genome Research Institute and institutions across the U.S. declare in a Leading Edge commentary in Cell.
Exelixis, Inc. today reported updated interim data from three ongoing trials of XL765 (SAR245409), an orally available small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mTOR. Activation of the PI3K pathway is a frequent event in human tumors, promoting cell proliferation, survival, and resistance to chemotherapy and radiotherapy.
New research led by Queen's University Belfast has discovered how a genomic approach to understanding bowel (colorectal) cancer could improve the prognosis and quality of life for patients.
The Methodist Neurological Institute's Eddy Scurlock Stroke Center, the largest stroke unit in Houston's Texas Medical Center, is the first hospital in the United States to receive a comprehensive stroke center certification by DNV Healthcare Inc.
Current research provides a novel model for rheumatoid arthritis research. The related report by LaBranche et al, "Characterization of the KRN cell transfer model of rheumatoid arthritis, a chronic yet synchronized version of the K/BxN mouse," appears in the September 2010 issue of The American Journal of Pathology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth P Moses, MD 2107 Livingston St, Suite A, Oakland, CA 94606-5218 Ph: (510) 436-9000 | Kenneth P Moses, MD 2107 Livingston St, Suite A, Oakland, CA 94606-5218 Ph: (510) 436-9000 |
News Archive
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory, National Human Genome Research Institute and institutions across the U.S. declare in a Leading Edge commentary in Cell.
Exelixis, Inc. today reported updated interim data from three ongoing trials of XL765 (SAR245409), an orally available small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mTOR. Activation of the PI3K pathway is a frequent event in human tumors, promoting cell proliferation, survival, and resistance to chemotherapy and radiotherapy.
New research led by Queen's University Belfast has discovered how a genomic approach to understanding bowel (colorectal) cancer could improve the prognosis and quality of life for patients.
The Methodist Neurological Institute's Eddy Scurlock Stroke Center, the largest stroke unit in Houston's Texas Medical Center, is the first hospital in the United States to receive a comprehensive stroke center certification by DNV Healthcare Inc.
Current research provides a novel model for rheumatoid arthritis research. The related report by LaBranche et al, "Characterization of the KRN cell transfer model of rheumatoid arthritis, a chronic yet synchronized version of the K/BxN mouse," appears in the September 2010 issue of The American Journal of Pathology.
› Verified 9 days ago
Daniel Mantuani, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1506 4th Ave Apt 5, Apt 5, Oakland, CA 94606 Phone: 504-390-5474 | |
Jennifer I. Harris, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 W Macarthur, Oakland, CA 94611 Phone: 510-752-1000 | |
Benjamin J. Bonnes, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1000 | |
Richard J. Knight, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1000 | |
Michael S. Gelfond, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 275 W Macarthur, Oakland, CA 94611 Phone: 510-752-1000 | |
Dr. Kayla Enriquez, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1411 E 31st St, Oakland, CA 94602 Phone: 510-437-4564 | |
Dr. Emily Meilan Sze, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Hawthorne Ave, Oakland, CA 94609 Phone: 510-869-2500 |